Literature DB >> 8077895

Acute cholestatic hepatitis and the sudden rise of the pacing threshold 5 weeks after VVI-pacemaker implantation.

R Schüppel1, M Probst.   

Abstract

The patient we describe developed a cholestatic hepatitis and an unusual threshold elevation of about 425%, coincidently, 5 weeks after pacemaker implantation. Lead dislocation, myocardial infarction or metabolic disorder could be excluded as a reason for the pacemaker complication. Neither a biliary obstruction nor an infection of the liver could be found to explain the liver injury. Most probably, both disorders were caused by propafenone (450 mg day-1), withdrawal of the drug resulted in normalization of elevated enzyme and threshold levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077895     DOI: 10.1111/j.1365-2796.1994.tb00808.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  1 in total

1.  Propafenone hepatotoxicity: report of two new cases.

Authors:  Daniel Cocozzella; José Curciarello; Osvaldo Corallini; Adriana Olivera; María Malca Alburquerque; Emilio Fraquelli; Liliana Zamagna; Alejandro Olenchuck; Alberto Cremona
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.